Likelihood of incidental finding of gynecological cancer in women undergoing hysterectomy for benign indications

被引:1
|
作者
Ekici, Mustafa Ayhan [1 ]
Onal, Ali Can [2 ]
Cetin, Caglar [3 ]
机构
[1] Abant Izzet Baysal Univ Hosp, Dept Gynecol & Obstet, TR-14280 Bolu, Turkey
[2] Abant Izzet Baysal Univ, Training & Res Hosp, Dept Pathol, TR-14280 Bolu, Turkey
[3] Bolu Izzet Baysal State Hosp, Dept Obstet & Gynecol, TR-14300 Bolu, Turkey
关键词
Hysterectomy; Uterine malignancy; Unexpected malignancy; Benign indication; Unexpected gynecologic malignancy; UTERINE PATHOLOGY; MALIGNANCY; RISK; TIME;
D O I
10.31083/j.ejgo.2020.03.5435
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to determine the incidence of unexpected gynecological malignancy (UGM) after hysterectomy performed for benign indications. Methods: We analysed patient sample data extracted from a medical database between 1 January 2007 and 10 August 2019 for 2740 women who underwent a hysterectomy for benign indications. The Kolmogorov-Smirnov test, KruskalWallis test and Chi-square test were performed. Statistical significance was reached if p < 0.05. Results : The most common primary indications for hysterectomy were leiomyomata (1403, 51%), abnormal uterine bleeding (784, 28.61%), and pelvic organ prolapse (504, 18.39%). A laparotomic, laparoscopic or vaginal hysterectomy was performed in 1452 (53%), 836 (30.5%) and 452 (16.5%) women, respectively. unexpected gynecological malignancy after hysterectomy was diagnosed in 22 (0.80%) women. The incidence of unexpected uterine malignancies (UUM), unexpected endometrial cancer, and unexpected uterine malignancies without endometrial cancer was 0.54%, 0.40% and 0.14% respectively. Mean ages were not significantly different for abdominal, laparoscopic and vaginal hysterectomy groups (51.75 +/- 9.83, 51.32 +/- 9.51, 51.39 +/- 10.04 years respectively, p = 0.299). No significant difference in the incidence of unexpected gynecological malignancy was noted between the groups [laparotomy 0.47%, laparoscopy 0.22%, vaginal 0.11%, p = 0.066]. The incidence of unexpected leiomyosarcoma [laparatomic 0.11%, laparascopic 0.03%, vaginal 0.0%] and unexpected endometrial carcinoma [laparatomic 0.26%, laparascopic 0.11%, vaginal 0.03%] was significantly higher in abdominal and laparascopic hysterectomy groups than the vaginal hysterectomy group and no significant difference was observed between the abdominal and laparoscopic hysterectomy groups (p = 0.037, p = 0.028, p = 0.108, respectively). Conclusion: The incidence of unexpected gynecological malignancy diagnosed after hysterectomy performed for benign conditions was very low, if the correct indications were selected.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 50 条
  • [31] Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study
    Multinu, Francesco
    Casarin, Jvan
    Tortorella, Lucia
    Huang, Yajue
    Weaver, Amy
    Angioni, Stefano
    Melis, Gian Benedetto
    Mariani, Andrea
    Stewart, Elizabeth A.
    Laughlin-Tommaso, Shannon K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (02) : 179.e1 - 179.e10
  • [32] The Prevalence of Occult Malignancy in Women Undergoing Hysterectomy or Myomectomy for Benign Indications and the Impact of Morcellation on Survival Outcomes: A Meta-Analysis
    Jiang, Dan
    Liu, Hongxuan
    Huang, Kui
    Chen, Yan
    Liu, Qiao
    Shu, Chuqiang
    Tian, Qi
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024,
  • [33] Risk Factors for Blood Transfusion in Women Undergoing Hysterectomy for Benign Disease
    Matthews, Catherine A.
    Cohen, Stephen
    Hull, Kathryn
    Ramakrishnan, Viswanathan
    Reid, Natasha
    JOURNAL OF GYNECOLOGIC SURGERY, 2012, 28 (02) : 108 - 112
  • [34] Risk Factors for Urologic Injury in Women Undergoing Hysterectomy for Benign Indication
    Nayak, Ameeta Lubina
    Breau, Rodney
    Hickling, Duane
    Pascali, Dante
    Clancy, Aisling
    Mallick, Ranjeeta
    Chen, Innie
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2022, 44 (04) : 247 - 254
  • [35] Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse
    Suphattanaporn, Ornthicha
    Saraluck, Apisith
    Mononai, Jittima
    Lekskul, Navamol
    Chinthakanan, Orawee
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [36] Ovarian cancer incidence and death in average-risk women undergoing bilateral oophorectomy at benign hysterectomy
    Cusimano, Maria
    Ferguson, Sarah
    Chiu, Maria
    Moineddin, Rahim
    Aktar, Suriya
    Liu, Ning
    Baxter, Nancy
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S224 - S224
  • [37] Cervical Elongation Among Patients Undergoing Vaginal Hysterectomy for Prolapse Versus Other Benign Indications
    Zeno, Aldene Olia Elio
    Takashima, Yoko
    Ghayouri, Sara
    Yazdany, Tajnoos
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 90S - 90S
  • [38] The effect of anemia severity on postoperative morbidity among patients undergoing laparoscopic hysterectomy for benign indications
    Tyan, Paul
    Taher, Ali
    Carey, Erin
    Sparks, Andrew
    Radwan, Amr
    Amdur, Richard
    Tamim, Hani
    Gu, Alex
    Robinson, Hannah
    Moawad, Gaby N.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (01) : 112 - 118
  • [39] Utility of preoperative laboratory evaluation in low-risk patients undergoing hysterectomy for benign indications
    Sears, Sarah
    Mangel, Jeffrey
    Adedayo, Pelumi
    Mims, Joseph
    Sundaresh, Shree
    Sheyn, David
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 248 : 144 - 149
  • [40] Incidence and outcomes of incidental endometrial carcinoma in women undergoing hysterectomy for pelvic organ prolapse
    Al-Hilli, Mariam
    Tewari, Surabhi
    Yao, Meng
    Propst, Katie
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S225 - S226